Penetrating Insights: Crossing the Cancer Cell Membrane to Improve Clinical Outcomes

Penetrating Insights: Crossing the Cancer Cell Membrane to Improve Clinical Outcomes Guest Editor: Eric K. Rowinsky Oncologist 2003; 8(Suppl 3): 1-45 Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional).

• Modifications to Therapy for Multiple Myeloma: Pegylated Liposomal Doxorubicin in Combination With Vincristine, Reduced-Dose Dexamethasone, and Thalidomide EXPIRED
• Blocked Pathways: FTIs Shut Down Oncogene Signals EXPIRED
• New Insights Into Erythropoietin and Epoetin Alfa: Mechanisms of Action, Target Tissues, and Clinical Applications EXPIRED
• Signal Events: Cell Signal Transduction and Its Inhibition in Cancer EXPIRED